ARGX vs GILD: Which Stock is Better?

Side-by-side comparison of Argenx Se and Gilead Sciences Inc in 2026

Comparison Updated:

ARGX

Argenx Se

$684.77

GILD

Gilead Sciences Inc

$141.29

Key Metrics Comparison

MetricARGXGILDWinner
Market Cap$43.69B$179.26BGILD
P/E Ratio36.1021.27GILD
EPS (TTM)$19.56$6.79ARGX
Revenue Growth0.7%0.0%ARGX
Gross Margin57.3%78.8%GILD

Analyze ARGX

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARGX or GILD a better investment?

Comparing ARGX and GILD: Argenx Se has a market cap of $43.69B while Gilead Sciences Inc has $179.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARGX and GILD?

ARGX (Argenx Se) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARGX or GILD?

Based on P/E ratios, GILD trades at a lower multiple (21.3x vs 36.1x).

Which is growing faster: ARGX or GILD?

ARGX has higher revenue growth at 0.7% vs 0.0% for GILD.

Which company is more profitable: ARGX or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 57.3% for ARGX.

Which is the larger company: ARGX or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $179.26B compared to $43.69B for ARGX.

Should I buy ARGX or GILD in 2026?

Both ARGX and GILD have investment merit. ARGX trades at $684.77 while GILD trades at $141.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARGX and GILD stock?

Key differences: Market Cap ($43.69B vs $179.26B), P/E Ratio (36.1x vs 21.3x), Revenue Growth (0.7% vs 0.0%), Gross Margin (57.3% vs 78.8%).

Popular Stock Comparisons